Rhythm Pharmaceuticals (RYTM) Treasury Shares (2016 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Treasury Shares came in at $115000.0 in Q1 2026, down 23.33% year-on-year from $150000.0 in Q1 2025, and down 13.21% on a QoQ basis from $132500.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Treasury Shares (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 8 years of Treasury Shares data on file, last reported at $115000.0 in Q1 2026.
- On a quarterly basis, Treasury Shares fell 23.33% year-over-year to $115000.0 in Q1 2026; TTM through Mar 2026 was $115000.0, a 23.33% decrease from a year earlier, with the FY2025 full-year figure at $132500.0, down 92.75% from the prior year.
- Treasury Shares for Q1 2026 stood at $115000.0, down from $132500.0 in the prior quarter.
- Over the last five years, Treasury Shares for RYTM reached as high as $804797.0 in Q4 2022 and fell as low as $115000.0 in Q1 2026.
- Historically, Treasury Shares has averaged $216921.9 across 4 years, with a median of $150000.0 in 2024.
- Across the five-year window, Treasury Shares surged 84.76% in 2022 and decreased 23.33% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $804797.0 in 2022, then slumped by 81.36% to $150000.0 in 2024, then decreased by 11.67% to $132500.0 in 2025, then fell by 13.21% to $115000.0 in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $115000.0 in Q1 2026, $132500.0 in Q4 2025, and $150000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn | 115,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115,000.00 |
| Mar 31, 2026 | 115,000.00 |
| Dec 31, 2025 | 132,500.00 |
| Dec 31, 2025 | 132,500.00 |
| Sep 30, 2025 | 150,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Dec 31, 2022 | 804,797.00 |
| Dec 31, 2022 | 804,797.00 |
| Dec 31, 2021 | 435,589.00 |
| Dec 31, 2021 | 435,589.00 |